We are live on ! Find out more
ITOS

iTeos Therapeutics
ITOS

Delisted

ITOS was delisted on the 28th of August, 2025.

Back to rankings

137 hedge funds and large institutions have $396M invested in iTeos Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 39

1.81% more ownership

Funds ownership: 99.18% → 100.99% (+1.8%)

2% more capital invested

Capital invested by funds: $389M → $396M (+$7.2M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 144 → 137 (-7)

14% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 36

86% less call options, than puts

Call options by funds: $2.04M | Put options by funds: $14.1M

Holders
137
Holders Change
-7
Holders Change %
-4.86%
% of All Funds
2%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
31
Increased
48
Reduced
39
Closed
36
Calls
$2.04M
Puts
$14.1M
Net Calls
-$12M
Net Calls Change
-$16.3M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$19.8M
2
EC
EcoR1 Capital
California
+$11.1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$3.02M
4
Citigroup
Citigroup
New York
+$2.56M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$10.2M
2
BlackRock
BlackRock
New York
-$7.82M
3
CS
Candriam SCA
Luxembourg
-$5.6M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$5.48M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$3.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
151
Adage Capital Partners
Massachusetts
– -$219K -20,000 Closed
LP
152
LMR Partners
United Kingdom
– -$197K -17,972 Closed
COPPSERS
153
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$194K -17,702 Closed
SOADOR
154
State of Alaska Department of Revenue
Alaska
– -$180K -16,485 Closed
PA
155
Profund Advisors
Maryland
– -$169K -15,429 Closed
State of Tennessee, Department of Treasury
156
State of Tennessee, Department of Treasury
Tennessee
– -$156K -14,260 Closed
LSERS
157
Louisiana State Employees Retirement System
Louisiana
– -$148K -13,500 Closed
Corient Private Wealth
158
Corient Private Wealth
Florida
– -$141K -12,889 Closed
SC
159
Syon Capital
California
– -$135K -12,368 Closed
Comerica Bank
160
Comerica Bank
Texas
– -$134K -12,243 Closed
GC
161
Guggenheim Capital
Illinois
– -$130K -11,861 Closed
OPERF
162
Oregon Public Employees Retirement Fund
Oregon
– -$86.7K -7,915 Closed
TRSOTSOK
163
Teachers Retirement System of the State of Kentucky
Kentucky
– -$72K -6,573 Closed
QT
164
Quantbot Technologies
New York
– -$51.5K -4,700 Closed
PMEF
165
Point72 Middle East FZE
United Arab Emirates
– -$24.5K -2,239 Closed
Amundi
166
Amundi
France
– -$16.3K -1,799 Closed
Point72 Asset Management
167
Point72 Asset Management
Connecticut
– -$10.1K -921 Closed
Fifth Third Bancorp
168
Fifth Third Bancorp
Ohio
– -$2.06K -188 Closed
PFBT
169
Parkside Financial Bank & Trust
Missouri
– -$1.05K -96 Closed
FMII
170
Farmers & Merchants Investments Inc
Nebraska
– -$153 -14 Closed
Nisa Investment Advisors
171
Nisa Investment Advisors
Missouri
– -$120 -11 Closed
C
172
Covestor
United Kingdom
– -$10 -1 -14%
CAL
173
Capital Advisors Ltd
Ohio
– +$99 +10 New
3 4 5 6
7

ITOS Hedge Fund Activity: Q4 2023 in Review

137 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in iTeos Therapeutics (ITOS) for Q4 2023, worth a combined $396M — up 1.9% from $389M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of ITOS and 31 opened new positions — a net loss of 5 holders — while 39 trimmed existing stakes and 48 added.

The largest buyer was Morgan Stanley, adding an estimated $19.8M. The largest seller was State Street, cutting an estimated $10.2M.

  • 137 institutional investors held iTeos Therapeutics (ITOS) as of Q4 2023, down from 144 in Q3 2023.
  • Funds reported $396M of iTeos Therapeutics stock for Q4 2023, up 1.9% quarter-over-quarter.
  • 31 funds opened new iTeos Therapeutics positions in Q4 2023 and 36 closed out, a net change of -5 holders.
  • The largest iTeos Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $19.8M added.
  • The largest iTeos Therapeutics seller in Q4 2023 was State Street, an estimated $10.2M sold.

Based on aggregated 13F filings for Q4 2023.